Close Menu

NYGC

The centers are using the standardized pipeline to help streamline data sharing and data analysis to achieve their larger research goals.

The researchers applied their so-called GWAX approach to study 12 common diseases in almost 120,000 individuals, confirming known and uncovering novel disease risk loci.

The center plans to offer the test for patients with undiagnosed disease and for disease predisposition testing in ostensibly healthy individuals.

The partners have committed to analyzing coding mutations, driver non-coding mutations, and structural variations across tumor types for the project.

Seeq has much in common with DNA.Land, launched last year, but targets individuals who have not used services from direct-to-consumer testing companies

Data from 43 genome-wide association studies have led researchers to individual variants and genetic factors that influence multiple phenotypes and conditions.

The partners plan to build a comprehensive repository that will contain genomic, exome, and phenotype data collected first from about 200 cancer patients. 

Dozens of government agencies, academic institutions, and a various public and private sector organizations have now committed to driving the initiative forward.

The Simons Foundation and the Carson Family Charitable Trust will match every dollar raised by the NYGC over the next three years up to $100 million.

As part of a course this fall, 20 undergraduate and graduate students used the MinIon in two hands-on "hackathon" sequencing projects.

Pages

A New Zealand minister says the country's genetic modification laws need to be re-examined to help combat climate change, the New Zealand Herald reports.

A new analysis finds some cancers receive more nonprofit dollars than others.

An Australian mother's conviction in the deaths of her children may be re-examined after finding that two of the children carried a cardiac arrhythmia-linked gene variant.

In Science this week: comparative analysis of sex differences in mammal gene expression, and more.